Zijian Deng1, Xiangkun Xu1, Tomas Garzon-Muvdi2, Yuanxuan Xia3, Eileen Kim3, Zineb Belcaid3, Andrew Luksik3, Russell Maxwell3, John Choi3, Hailun Wang1, Jingjing Yu4, Iulian Iordachita5, Michael Lim3, John W Wong1, Ken Kang-Hsin Wang6. 1. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas. 3. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. School of Physics and Information Technology, Shaanxi Normal University, Shanxi, China. 5. Laboratory for Computational Sensing and Robotics, Johns Hopkins University, Baltimore, Maryland. 6. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: kwang27@jhmi.edu.
Abstract
PURPOSE: The cone-beam computed tomography (CBCT)-guided small animal radiation research platform (SARRP) has provided unique opportunities to test radiobiologic hypotheses. However, CBCT is less adept to localize soft tissue targets growing in a low imaging contrast environment. Three-dimensional bioluminescence tomography (BLT) provides strong image contrast and thus offers an attractive solution. We introduced a novel and efficient BLT-guided conformal radiation therapy and demonstrated it in an orthotopic glioblastoma (GBM) model. METHODS AND MATERIALS: A multispectral BLT system was integrated with SARRP for radiation therapy (RT) guidance. GBM growth curve was first established by contrast CBCT/magnetic resonance imaging (MRI) to derive equivalent sphere as approximated gross target volume (aGTV). For BLT, mice were subject to multispectral bioluminescence imaging, followed by SARRP CBCT imaging and optical reconstruction. The CBCT image was acquired to generate anatomic mesh for the reconstruction and RT planning. To ensure high accuracy of the BLT-reconstructed center of mass (CoM) for target localization, we optimized the optical absorption coefficients μa by minimizing the distance between the CoMs of BLT reconstruction and contrast CBCT/MRI-delineated GBM volume. The aGTV combined with the uncertainties of BLT CoM localization and target volume determination was used to generate estimated target volume (ETV). For conformal irradiation procedure, the GBM was first localized by the predetermined ETV centered at BLT-reconstructed CoM, followed by SARRP radiation. The irradiation accuracy was qualitatively confirmed by pathologic staining. RESULTS: Deviation between CoMs of BLT reconstruction and contrast CBCT/MRI-imaged GBM is approximately 1 mm. Our derived ETV centered at BLT-reconstructed CoM covers >95% of the tumor volume. Using the second-week GBM as an example, the ETV-based BLT-guided irradiation can cover 95.4% ± 4.7% tumor volume at prescribed dose. The pathologic staining demonstrated the BLT-guided irradiated area overlapped well with the GBM location. CONCLUSIONS: The BLT-guided RT enables 3-dimensional conformal radiation for important orthotopic tumor models, which provides investigators a new preclinical research capability.
PURPOSE: The cone-beam computed tomography (CBCT)-guided small animal radiation research platform (SARRP) has provided unique opportunities to test radiobiologic hypotheses. However, CBCT is less adept to localize soft tissue targets growing in a low imaging contrast environment. Three-dimensional bioluminescence tomography (BLT) provides strong image contrast and thus offers an attractive solution. We introduced a novel and efficient BLT-guided conformal radiation therapy and demonstrated it in an orthotopic glioblastoma (GBM) model. METHODS AND MATERIALS: A multispectral BLT system was integrated with SARRP for radiation therapy (RT) guidance. GBM growth curve was first established by contrast CBCT/magnetic resonance imaging (MRI) to derive equivalent sphere as approximated gross target volume (aGTV). For BLT, mice were subject to multispectral bioluminescence imaging, followed by SARRP CBCT imaging and optical reconstruction. The CBCT image was acquired to generate anatomic mesh for the reconstruction and RT planning. To ensure high accuracy of the BLT-reconstructed center of mass (CoM) for target localization, we optimized the optical absorption coefficients μa by minimizing the distance between the CoMs of BLT reconstruction and contrast CBCT/MRI-delineated GBM volume. The aGTV combined with the uncertainties of BLT CoM localization and target volume determination was used to generate estimated target volume (ETV). For conformal irradiation procedure, the GBM was first localized by the predetermined ETV centered at BLT-reconstructed CoM, followed by SARRP radiation. The irradiation accuracy was qualitatively confirmed by pathologic staining. RESULTS: Deviation between CoMs of BLT reconstruction and contrast CBCT/MRI-imaged GBM is approximately 1 mm. Our derived ETV centered at BLT-reconstructed CoM covers >95% of the tumor volume. Using the second-week GBM as an example, the ETV-based BLT-guided irradiation can cover 95.4% ± 4.7% tumor volume at prescribed dose. The pathologic staining demonstrated the BLT-guided irradiated area overlapped well with the GBM location. CONCLUSIONS: The BLT-guided RT enables 3-dimensional conformal radiation for important orthotopic tumor models, which provides investigators a new preclinical research capability.
Authors: Yidong Yang; Ken Kang-Hsin Wang; Sohrab Eslami; Iulian I Iordachita; Michael S Patterson; John W Wong Journal: Med Phys Date: 2015-04 Impact factor: 4.071
Authors: Nikolay L Martirosyan; Daniel D Cavalcanti; Jennifer M Eschbacher; Peter M Delaney; Adrienne C Scheck; Mohammed G Abdelwahab; Peter Nakaji; Robert F Spetzler; Mark C Preul Journal: J Neurosurg Date: 2011-09-16 Impact factor: 5.115
Authors: John Wong; Elwood Armour; Peter Kazanzides; Iulian Iordachita; Erik Tryggestad; Hua Deng; Mohammad Matinfar; Christopher Kennedy; Zejian Liu; Timothy Chan; Owen Gray; Frank Verhaegen; Todd McNutt; Eric Ford; Theodore L DeWeese Journal: Int J Radiat Oncol Biol Phys Date: 2008-08-01 Impact factor: 7.038
Authors: Grit S Herter-Sprie; Houari Korideck; Camilla L Christensen; Jan M Herter; Kevin Rhee; Ross I Berbeco; David G Bennett; Esra A Akbay; David Kozono; Raymond H Mak; G Mike Makrigiorgos; Alec C Kimmelman; Kwok-Kin Wong Journal: Nat Commun Date: 2014-12-18 Impact factor: 14.919
Authors: Lisa A Feldman; Marie-Sophie Fabre; Carole Grasso; Dana Reid; William C Broaddus; Gregory M Lanza; Bruce D Spiess; Joel R Garbow; Melanie J McConnell; Patries M Herst Journal: PLoS One Date: 2017-09-05 Impact factor: 3.240
Authors: Zijian Deng; Xiangkun Xu; Hamid Dehghani; Daniel M Sforza; Iulian Iordachita; Michael Lim; John W Wong; Ken Kang-Hsin Wang Journal: Methods Mol Biol Date: 2022
Authors: Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason Journal: Molecules Date: 2021-04-27 Impact factor: 4.411
Authors: Xiangkun Xu; Zijian Deng; Hamid Dehghani; Iulian Iordachita; Michael Lim; John W Wong; Ken Kang-Hsin Wang Journal: Int J Radiat Oncol Biol Phys Date: 2021-08-16 Impact factor: 7.038